Resisting recommended treatment for prostate cancer: a qualitative analysis of the lived experience of possible overdiagnosis.
Kirsten Jo McCafferyBrooke NickelKristen M PicklesRay MoynihanBarnett KramerAlexandra BarrattJolyn K HerschPublished in: BMJ open (2019)
Men who choose not to have recommended treatment for prostate cancer may avoid treatment-associated harms like incontinence and impotence, however our findings showed that the impact of the diagnosis itself is immense and far-reaching. A high priority for improving clinical practice is to ensure men are adequately informed of these potential consequences before screening is considered.